CAS Number28047-15-6
SynonymsN(2)-phenylacetyl-L-glutamine; (2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid; N-[(4-Hydroxyphenyl)acetyl]glutamic acid; Phenylacetyl L-Glutamine
Molecular FormulaC13H16N2O4
Molecular Weight264.28
Purity≥95%
Density1.4±0.1 g/cm3
Boiling Point646.6±55.0 °C at 760 mmHg
Melting Point85-87?C
Appearancepowder
EINECS0
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 28047-15-6 |
| Catalog No. | 2A-0101778 |
| Chinese Name | N-苯乙酰基-L-谷氨酰胺 |
| Synonyms | N(2)-phenylacetyl-L-glutamine; (2S)-5-amino-5-oxo-2-[(2-phenylacetyl)amino]pentanoic acid; N-[(4-Hydroxyphenyl)acetyl]glutamic acid; Phenylacetyl L-Glutamine |
| Molecular Formula | C13H16N2O4 |
| Molecular Weight | 264.28 |
| Purity | ≥95 |
| Density | 1.4±0.1 g/cm3 |
| Boiling Point | 646.6±55.0 °C at 760 mmHg |
| Melting Point | 85-87?C |
| Appearance | powder |
| Storage Condition | Store at 0-5°C |
| Application | Phenylacetylglutamine is a colonic microbial metabolite derived from amino acid fermentation. |
| EINECS | 0 |
| HTC | 2924299090 |
| UN(IATA) | 0 |
| PubChem ID | 6833 |
| MDL Number | MFCD01725188 |
| SMILES | N([C@@H](CCC(=O)N)C(=O)O)C(=O)Cc1ccccc1 |
| InChI | 1S/C13H16N2O4/c14-11(16)7-6-10(13(18)19)15-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,17)(H,18,19)/t10-/m0/s1 |
| InChI Key | JFLIEFSWGNOPJJ-JTQLQIEISA-N |
| NACRES Code | NA.26 |
| UNSPSC | 12352209 |
| MSDS | msds/101778_1_28047_15_6.pdf |
| Bioactivity | Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation. Related Catalog Research Areas >> Others Natural Products >> Others Target Human Endogenous Metabolite In Vitro Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation. It results from glutamine conjugation of phenylacetic acid, which is almost exclusively derived from the microbial conversion of phenylalanine[1]. References [1]. Poesen R, et al. Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. J Am Soc Nephrol. 2016 Nov;27(11):3479-3487. Chemical & Physical Properties Density 1.4±0.1 g/cm3 Boiling Point 646.6±55.0 °C at 760 mmHg Melting Point 85-87?C Molecular Formula C13H16N2O4 Molecular Weight 281.261 Flash Point 344.9±31.5 °C Exact Mass 281.089935 PSA 109.49000 LogP -1.38 Vapour Pressure 0.0±2.0 mmHg at 25°C Index of Refraction 1.595 InChIKey JFLIEFSWGNOPJJ-JTQLQIEISA-N SMILES NC(=O)CCC(NC(=O)Cc1ccccc1)C(=O)O Storage condition Store at 0-5°C |
| Use of | Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation. Properties Name N2-phenylacetyl-L-glutamine Synonym More Synonyms N-[(4-Hydroxyphenyl)acetyl]glutamic acid Biological Activity Description Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation. Related Catalog Research Areas >> Others Natural Products >> Others Human Endogenous Metabolite In Vitro Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation. It results from glutamine conjugation of phenylacetic acid, which is almost exclusively derived from the microbial conversion of phenylalanine[1]. References [1]. Poesen R, et al. Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD. J Am Soc Nephrol. 2016 Nov;27(11):3479-3487. Chemical & Physical Properties Molecular Formula C13H16N2O4 Exact Mass 281.089935 PSA 109.49000 LogP -1.38 Index of Refraction 1.595 InChIKey JFLIEFSWGNOPJJ-JTQLQIEISA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 30.0% |
| Transport Info | Product name: Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-5-(TERT-BUTOXYCARBONYL)-5-AZASPIRO[2.4]HEPTANE-6-CARBOXYLIC ACID | 1129634-44-1 | 2A-0101772 |
| (S)-5-AMINO-2-((2,4-DINITROPHENYL)AMINO)-5-OXOPENTANOIC ACID | 1602-41-1 | 2A-0101773 |
| (S)-5-AMINO-2-((R)-2-CHLOROPROPANAMIDO)-5-OXOPENTANOIC ACID | 159141-33-0 | 2A-0101774 |
| (S)-5-AMINO-2-((S)-2-AMINO-3-CARBOXYPROPANAMIDO)-5-OXOPENTANOIC ACID | 13433-13-1 | 2A-0101775 |
| (S)-5-AMINO-2-(2-AMINOACETAMIDO)-5-OXOPENTANOIC ACID HYDRATE | 131115-71-4 | 2A-0101776 |
| (S)-5-BENZYL-3-METHYLIMIDAZOLIDINE-2,4-DIONE | 16935-42-5 | 2A-0101788 |
| (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE | 903557-29-9 | 2A-0101789 |
| (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE HYDROCHLORIDE | 916210-93-0 | 2A-0101790 |
| (S)-5-BROMO-N-((1-ETHYLPYRROLIDIN-2-YL)METHYL)-2,3-DIMETHOXYBENZAMIDE | 107188-74-9 | 2A-0101791 |
| (S)-5-CHLORO-2,3-DIHYDRO-1H-INDEN-1-AMINE | 945950-78-7 | 2A-1101792 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS